Ovarian cancer
Results
Phase 2
This trial looked at a drug called epacadostat for women with ovarian cancer who had no signs of cancer after chemotherapy. But who then had a raised level of a marker called CA125 in their blood a few months later. The trial was for women who had:
These cancers are all treated in the same way. So, when we use the term ovarian cancer in this summary, we are referring to all 3.
Recruitment start: 7 March 2013
Recruitment end: 27 March 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Rebecca Kristeleit
Incyte Corporation
Last reviewed: 9 January 2019
CRUK internal database number: 10816